Report Thumbnail
Product Code OM091491345B5I
Published Date 2022/7/23
English PagesGlobal

Tissue-Replacement Products Market 2022-2028MedicalDevice_MedTech Market


Report Thumbnail
Product Code OM091491345B5I◆The Jul 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2022/7/23
English PagesGlobal

Tissue-Replacement Products Market 2022-2028MedicalDevice_MedTech Market



Abstract


Summary

Global Tissue-Replacement Products Market Size, Share, and Trends Analysis Report, By Product Type (Tissue Patch/Mesh, Cellular Regeneration, Suture Anchor, Laparoscopic Instruments, and Others), By Application (Craniomaxillofacial (CMF) Surgery, Orthopedic Surgery, Spinal Fusion Surgery, Dental Implant Surgery, Bone Growth Factor Delivery, and Breast Reconstruction), By End-User (Hospitals, Specialized Clinics, Ambulatory Surgical Centers, and Research & Academic Institutions), Forecast Period (2022-2028) The global tissue-replacement products market is anticipated to grow at a CAGR of 4.2% during the forecast period. The market growth is driven by emerging trends which include advancements in cell therapy and tissue engineering and the significant prevalence of chronic diseases such as cystic fibrosis, hepatitis, cardiovascular disorders, and cancer. In addition, the growing geriatric population which is prone to various soft tissue injuries such as muscles, tendons, and ligaments is expected to create potential demand for tissue-replacement products. In addition, increasing sports injuries is also a key factor in the demand for tissue-replacement products. In the US, about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year. Moreover, more than 775,000 children, ages 14 and younger, are treated in hospital emergency rooms for sports-related injuries each year in the US, which in turn, is driving the demand for tissue-replacement products. The global tissue-replacement products market is segmented based on product type, application, and end-user. Based on product type, the market is segmented into tissue patch/mesh, cellular regeneration, suture anchor, laparoscopic instruments, and others. Based on application, the market is segmented into craniomaxillofacial (CMF) surgery, orthopedic surgery, spinal fusion surgery, dental implant surgery, bone growth factor delivery, and breast reconstruction. Based on end-user, the market is segmented into hospitals, specialized clinics, ambulatory surgical centers, and research & academic institutions. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to contribute the largest share in the market growth owing to the rising prevalence of orthopedic conditions that has surged the demand for orthopedic regenerative surgical products for joint pain, gout, articular defects, fibromyalgia, and osteoarthritis, to trauma and joint replacement. The major players operating in the global tissue-replacement products market include Medtronic plc, Johnson & Johnson Services, Inc., and Smith & Nephew plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. Research Methodology The market study of the global tissue-replacement products is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports. Secondary Sources Include • Financial reports of companies involved in the market. • Whitepapers, research papers, and news blogs. • Company websites and their product catalog. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models. Market Segmentation 1. Global Tissue-Replacement Products Research and Analysis by Product Type 2. Global Tissue-Replacement Products Research and Analysis by Application 3. Global Tissue-Replacement Products Research and Analysis by End-User The Report Covers • Comprehensive research methodology of the global tissue-replacement products market. • This report also includes a detailed and extensive market overview with key analyst insights. • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. • Analysis of regional regulations and other government policies impacting the global Tissue-Replacement Products market. • Insights about market determinants that are stimulating the global tissue-replacement products market. • Detailed and extensive market segments with the regional distribution of forecasted revenues. • Extensive profiles and recent developments of market players.

Table of Contents

  • 1 Report Summary

    • 1.1 Research Methods and Tools
    • 1.2 Market Breakdown
      • 1.2.1 By Segments
      • 1.2.2 By Region
  • 2 Market Overview and Insights

    • 2.1 Scope of the Report
    • 2.2 Analyst Insight & Current Market Trends
      • 2.2.1 Key Findings
      • 2.2.2 Recommendations
      • 2.2.3 Conclusion
  • 3 Competitive Landscape

    • 3.1 Key Company Analysis
      • 3.1.1 Overview
      • 3.1.2 Financial Analysis
      • 3.1.3 SWOT Analysis
      • 3.1.4 Recent Developments
    • 3.2 Key Strategy Analysis
  • 4 Market Segmentation

    • 4.1 Global Tissue-Replacement Products Market by Product Type
      • 4.1.1 Tissue Patch/Mesh
      • 4.1.2 Cellular Regeneration
      • 4.1.3 Suture Anchor
      • 4.1.4 Laparoscopic Instruments
      • 4.1.5 Others
    • 4.2 Global Tissue-Replacement Products Market by Application
      • 4.2.1 Craniomaxillofacial (CMF) Surgery
      • 4.2.2 Orthopedic Surgery
      • 4.2.3 Spinal Fusion Surgery
      • 4.2.4 Dental Implant Surgery
      • 4.2.5 Bone Growth Factor Delivery
      • 4.2.6 Breast Reconstruction
    • 4.3 Global Tissue-Replacement Products Market by End-User
      • 4.3.1 Hospitals
      • 4.3.2 Specialized Clinics
      • 4.3.3 Ambulatory Surgical Centers
      • 4.3.4 Research & Academic Institutions
  • 5 Regional Analysis

    • 5.1 North America
      • 5.1.1 United States
      • 5.1.2 Canada
    • 5.2 Europe
      • 5.2.1 UK
      • 5.2.2 Germany
      • 5.2.3 Italy
      • 5.2.4 Spain
      • 5.2.5 France
      • 5.2.6 Rest of Europe
    • 5.3 Asia-Pacific
      • 5.3.1 China
      • 5.3.2 India
      • 5.3.3 Japan
      • 5.3.4 South Korea
      • 5.3.5 Rest of Asia-Pacific
    • 5.4 Rest of the World
      • 5.4.1 Latin America
      • 5.4.2 Middle East & Africa
  • 6 Company Profiles

    • 6.1 ACell, Inc
    • 6.2 Allergan plc
    • 6.3 Arthrex, Inc
    • 6.4 Boston Scientific Corp
    • 6.5 C.R. Bard, Inc. (A Becton, Dickinson and Co.)
    • 6.6 Cook Medical, Inc
    • 6.7 Edwards Lifesciences
    • 6.8 Herniamesh S.r.l
    • 6.9 Integra LifeSciences Corp
    • 6.10 Johnson & Johnson Services, Inc
    • 6.11 Koninklijke DSM N.V
    • 6.12 MAQUET Holding B.V. & Co. KG
    • 6.13 Meccellis Biotech
    • 6.14 Medtronic, PLC
    • 6.15 Organogenesis, Inc
    • 6.16 Smith & Nephew plc
    • 6.17 StrataGraft
    • 6.18 Stryker Corp
    • 6.19 TELA Bio, Inc
    • 6.20 Via Surgical Ltd
    • 6.21 Wright Medical Group N.V
    • 6.22 Zimmer Biomet Holdings, Inc
USD 5,125 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.